Compounds > cidofovir anhydrous
Page last updated: 2024-08-24

cidofovir anhydrous and Benign Neoplasms, Brain

cidofovir anhydrous has been researched along with Benign Neoplasms, Brain in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cobbs, CS; Fiallos, E; Hadaczek, P; James, CD; Matlaf, L; Ozawa, T; Singer, E; Soroceanu, L; Yoshida, Y1
Basile, U; Iorio, R; Lauriola, L; Mirabella, M; Ricci, E; Sabatelli, M; Tartaglione, R; Tasca, G1
Andrei, G; De Clercq, E; Liekens, S; Neyts, J; Vandeputte, M1
De Clercq, E; Liekens, S; Neyts, J; Verbeken, E1
De Clercq, E; Liekens, S; Neyts, J; Presta, M; Ribatti, D; Verbeken, E1

Other Studies

5 other study(ies) available for cidofovir anhydrous and Benign Neoplasms, Brain

ArticleYear
Cidofovir: a novel antitumor agent for glioblastoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Dec-01, Volume: 19, Issue:23

    Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cidofovir; Cytosine; DNA Breaks, Double-Stranded; DNA Replication; Female; Glioblastoma; Humans; Mice; Mice, Nude; Organophosphonates; Spheroids, Cellular; Tumor Burden; Xenograft Model Antitumor Assays

2013
Progressive multifocal leukoencephalopathy in a patient with Franklin disease and hypogammaglobulinemia.
    Journal of the neurological sciences, 2009, Sep-15, Volume: 284, Issue:1-2

    Topics: Adenocarcinoma; Agammaglobulinemia; Aged; Antiviral Agents; Brain; Brain Neoplasms; Cidofovir; Cytosine; Diagnosis, Differential; Fatal Outcome; Heavy Chain Disease; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Organophosphonates; Paraneoplastic Syndromes; Rectal Neoplasms; Risk Factors; Virus Activation

2009
Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir.
    Cancer research, 1998, Jun-15, Volume: 58, Issue:12

    Topics: Animals; Antiviral Agents; Body Weight; Brain Neoplasms; Cidofovir; Cytosine; Hemangioma; Incidence; Organophosphonates; Organophosphorus Compounds; Polyomavirus; Rats; Rats, Wistar; Skin Neoplasms; Survival Analysis

1998
Potent inhibition of hemangiosarcoma development in mice by cidofovir.
    International journal of cancer, 2001, Apr-15, Volume: 92, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Division; Cell Line, Transformed; Cidofovir; Cytosine; Female; Hemangiosarcoma; Mice; Mice, Nude; Mice, SCID; Neoplasm Transplantation; Organophosphonates; Organophosphorus Compounds; Peritoneal Neoplasms; Survival Rate

2001
Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir.
    Cancer research, 2001, Jul-01, Volume: 61, Issue:13

    Topics: Animals; Antineoplastic Agents; Antiviral Agents; Apoptosis; Brain Neoplasms; Cell Division; Chick Embryo; Cidofovir; Cytosine; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Hemangioendothelioma; Mice; Mice, Nude; Mice, SCID; Neovascularization, Pathologic; Neovascularization, Physiologic; Organophosphonates; Organophosphorus Compounds; Transfection; Tumor Cells, Cultured

2001